Hepatitis-C eradication by 2030, as required by the WHO, is within reach in Spain. Dr. Joaquin Cabezas explains how the country is making prisons HCV-free by near 100% diagnosis and 100% treatment.
NAFLD is a form of fatty liver (steatosis hepatitis) not caused by increased alcohol consumption. The prevalence in Europe is estimated to be between 20 and 30%.
Chronic liver disease is on the rise. Aside from undetected liver disease, abnormal liver function tests are often not followed up in primary care, or many patients ignore their follow-up appointments.
Hepatitis E represents a major health challenge worldwide and is still difficult to control. For example, prevention in disinfection is reaching its limits and vaccination is currently only available in China.
How does COVID-19 affect patients with liver disease? This was the topic of a special online session at the EASL digital congress 2020.
Prof. Bajaj discusses his latest research on how fecal microbiota transplants reduce short-term cravings, improve life quality, and increase microbial diversity in cirrhosis and alcohol consumption disorders.
HIV coinfection is quite common in HCV patients. However, little research has been done on the influence of such co-infections on the morbidity and mortality of those affected.
With the help of the Europe-wide PREDICT study, an international research association determined three forms of acute decompensated liver cirrhosis.
Researchers identified a microRNA in obese female mice that transmit a potential risk of liver cancer to their offspring over generations.
Repeated measurement of the FIB-4 index score over several years helps to assess the risk of developing a serious liver disease such as cirrhosis, according to a recent study from Sweden.